Literature DB >> 28365303

Quasi-experimental study designs series-paper 4: uses and value.

Till Bärnighausen1, Peter Tugwell2, John-Arne Røttingen3, Ian Shemilt4, Peter Rockers5, Pascal Geldsetzer6, John Lavis7, Jeremy Grimshaw8, Karen Daniels9, Annette Brown10, Jacob Bor11, Jeffery Tanner12, Arash Rashidian13, Mauricio Barreto14, Sebastian Vollmer15, Rifat Atun6.   

Abstract

Quasi-experimental studies are increasingly used to establish causal relationships in epidemiology and health systems research. Quasi-experimental studies offer important opportunities to increase and improve evidence on causal effects: (1) they can generate causal evidence when randomized controlled trials are impossible; (2) they typically generate causal evidence with a high degree of external validity; (3) they avoid the threats to internal validity that arise when participants in nonblinded experiments change their behavior in response to the experimental assignment to either intervention or control arm (such as compensatory rivalry or resentful demoralization); (4) they are often well suited to generate causal evidence on long-term health outcomes of an intervention, as well as nonhealth outcomes such as economic and social consequences; and (5) they can often generate evidence faster and at lower cost than experiments and other intervention studies.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28365303     DOI: 10.1016/j.jclinepi.2017.03.012

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   7.407


  34 in total

1.  Population health intervention research: three important advancements.

Authors:  Till Bärnighausen
Journal:  Int J Public Health       Date:  2017-06-06       Impact factor: 3.380

2.  Regression discontinuity analysis demonstrated varied effect of Treat-All on CD4 testing among Southern African countries.

Authors:  Elizabeth Zaniewski; Ellen Brazier; Cam Ha Dao Ostinelli; Robin Wood; Meg Osler; Karl-Günter Technau; Joep J van Oosterhout; Nicola Maxwell; Janneke van Dijk; Hans Prozesky; Matthew P Fox; Jacob Bor; Denis Nash; Matthias Egger
Journal:  J Clin Epidemiol       Date:  2021-09-03       Impact factor: 6.437

Review 3.  Knowledge gaps in diabetes research: an evidence mapping of the literature.

Authors:  Shahnaz Esmaeili; Fatemeh Bandarian; Fatemeh Gharishvandi; Farideh Razi; Shaghayegh Hosseinkhani; Nazli Namazi; Behnaz Esmaeili; Mahnaz Sanjari; Ali Tootee; Saeedeh Saeedi; Camelia Rambod; Maryam Aalaa; Noushin Fahimfar; Bagher Larijani; Ensieh Nasli-Esfahani
Journal:  J Diabetes Metab Disord       Date:  2022-05-25

4.  Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.

Authors:  Shari Krishnaratne; Lisa M Pfadenhauer; Michaela Coenen; Karin Geffert; Caroline Jung-Sievers; Carmen Klinger; Suzie Kratzer; Hannah Littlecott; Ani Movsisyan; Julia E Rabe; Eva Rehfuess; Kerstin Sell; Brigitte Strahwald; Jan M Stratil; Stephan Voss; Katharina Wabnitz; Jacob Burns
Journal:  Cochrane Database Syst Rev       Date:  2020-12-17

5.  Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.

Authors:  Jacob Bor; Matthew P Fox; Sydney Rosen; Atheendar Venkataramani; Frank Tanser; Deenan Pillay; Till Bärnighausen
Journal:  PLoS Med       Date:  2017-11-28       Impact factor: 11.613

6.  Quasi-experimental study designs series-paper 5: a checklist for classifying studies evaluating the effects on health interventions-a taxonomy without labels.

Authors:  Barnaby C Reeves; George A Wells; Hugh Waddington
Journal:  J Clin Epidemiol       Date:  2017-03-27       Impact factor: 6.437

7.  The public health value of vaccines beyond efficacy: methods, measures and outcomes.

Authors:  A Wilder-Smith; I Longini; P L Zuber; T Bärnighausen; W J Edmunds; N Dean; V Masserey Spicher; M R Benissa; B D Gessner
Journal:  BMC Med       Date:  2017-07-26       Impact factor: 8.775

8.  Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia.

Authors:  Aaloke Mody; Izukanji Sikazwe; Nancy L Czaicki; Mwanza Wa Mwanza; Theodora Savory; Kombatende Sikombe; Laura K Beres; Paul Somwe; Monika Roy; Jake M Pry; Nancy Padian; Carolyn Bolton-Moore; Charles B Holmes; Elvin H Geng
Journal:  PLoS Med       Date:  2018-06-05       Impact factor: 11.069

9.  Long term effect of primary health care training on HIV testing: A quasi-experimental evaluation of the Sexual Health in Practice (SHIP) intervention.

Authors:  Kamla Pillay; Melissa Gardner; Allon Gould; Susan Otiti; Judith Mullineux; Till Bärnighausen; Philippa Margaret Matthews
Journal:  PLoS One       Date:  2018-08-01       Impact factor: 3.240

10.  The effect of eligibility for antiretroviral therapy on body mass index and blood pressure in KwaZulu-Natal, South Africa.

Authors:  Aditi Kuber; Anna Reuter; Pascal Geldsetzer; Natsayi Chimbindi; Mosa Moshabela; Frank Tanser; Till Bärnighausen; Sebastian Vollmer
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.